Manifestações clínicas relacionadas ao sistema nervoso decorrentes da COVID-19: uma revisão integrativa

Bianca Sampaio  Lima; Brenda Ellen Meneses  Cardoso; Louise Ribeiro  Teixeira; André Pessoa Silva de  Bastos; Francisco Lucas Lima  Paz; José Guilherme de Oliveira Rodrigues  Ferreira; Gabriela de Souza  Mendonça; Rafaela Costa  Pacheco; Larruama Soares Figueiredo de  Araújo; Humberto Gabriel de  Albuquerque; Charles Ponte de  Sousa Filho; Ligia Viana de  Araujo; Joilson Ramos de  Jesus; Luan Kelves Miranda de  Souza

doi:10.33448/rsd-v11i5.27745

Autores/as

Bianca Sampaio Lima Instituto de Educação Superior do Vale do Parnaíba SA, IESVAP/FAHESP https://orcid.org/0000-0002-0574-4936
Brenda Ellen Meneses Cardoso Instituto de Educação Superior do Vale do Parnaíba SA, IESVAP/FAHESP https://orcid.org/0000-0002-5982-5985
Louise Ribeiro Teixeira Instituto de Educação Superior do Vale do Parnaíba SA, IESVAP/FAHESP https://orcid.org/0000-0001-7378-1096
André Pessoa Silva de Bastos Instituto de Educação Superior do Vale do Parnaíba SA, IESVAP/FAHESP https://orcid.org/0000-0002-1188-0766
Francisco Lucas Lima Paz Instituto de Educação Superior do Vale do Parnaíba SA, IESVAP/FAHESP https://orcid.org/0000-0002-1788-1137
José Guilherme de Oliveira Rodrigues Ferreira Instituto de Educação Superior do Vale do Parnaíba SA, IESVAP/FAHESP https://orcid.org/0000-0002-2617-5146
Gabriela de Souza Mendonça Instituto de Educação Superior do Vale do Parnaíba SA, IESVAP/FAHESP https://orcid.org/0000-0002-7922-5995
Rafaela Costa Pacheco Instituto de Educação Superior do Vale do Parnaíba SA, IESVAP/FAHESP https://orcid.org/0000-0001-8477-8298
Larruama Soares Figueiredo de Araújo Instituto de Educação Superior do Vale do Parnaíba SA, IESVAP/FAHESP https://orcid.org/0000-0002-0902-9200
Humberto Gabriel de Albuquerque Instituto de Educação Superior do Vale do Parnaíba SA, IESVAP/FAHESP https://orcid.org/0000-0003-2371-1182
Charles Ponte de Sousa Filho Instituto de Educação Superior do Vale do Parnaíba SA, IESVAP/FAHESP https://orcid.org/0000-0002-0943-410X
Ligia Viana de Araujo Instituto de Educação Superior do Vale do Parnaíba SA, IESVAP/FAHESP https://orcid.org/0000-0002-0674-4604
Joilson Ramos de Jesus Instituto de Educação Superior do Vale do Parnaíba SA, IESVAP/FAHESP https://orcid.org/0000-0002-8167-524X
Luan Kelves Miranda de Souza Instituto de Educação Superior do Vale do Parnaíba SA, IESVAP/FAHESP https://orcid.org/0000-0002-8019-4022

DOI:

https://doi.org/10.33448/rsd-v11i5.27745

Palabras clave:

Coronavirus; Enfermedades neurodegenerativas; Manifestaciones neurológicas.

Resumen

Objective: to analyze the main neurological disorders resulting from infection by the SARS-CoV-2 virus (severe acute respiratory syndrome coronavirus 2) through an integrative review. Methodology: this is an integrative literature review study. For the selection of articles, two databases were used: PUBMED and Scielo, and the following inclusion criteria were established: case report studies and clinical studies, carried out in human beings, available in English, Spanish and Portuguese, attributing the time cut of 1 year (2020-2021). The final sample used in this review consisted of 36 articles. Results and discussion: although the main target is the human respiratory system, the coronavirus has neurotropic and neuroinvasive potential, having the ability to reach the central nervous system (CNS). Thus, studies have shown associations between SARS-Cov-2 infection and the occurrence of headache, encephalopathy, cerebrovascular disease, cerebral hemorrhage, encephalomyelitis, impaired consciousness and delirium, tonic-clonic seizures, impaired smell and taste, Guillain-Barré syndrome, rhabdomyolysis, Parkinson's disease, Alzheimer's and multiple sclerosis. Conclusion: from the current literature review, it is inferred that the rates of neurological impairment in cases of COVID-19 are significant and demand the development of more studies on the subject.

Citas

Acar, T., Acar, B. A., Aras, Y. G., Doğan, T., Boncuk, S., Eryılmaz, Halil Alper, Can, N., & Can, Y. (2020). Demographic characteristics and neurological comorbidity of patients with COVID-19. Revista Da Associação Médica Brasileira, 66, 82–85.

Acharya, A., Kevadiya, B. D., Gendelman, H. E., & Byrareddy, S. N. (2020). SARS-CoV-2 Infection Leads to Neurological Dysfunction. Journal of Neuroimmune Pharmacology: The Official Journal of the Society on NeuroImmune Pharmacology, 15(2), 167–173.

Asadi-Pooya, A. A., & Simani, L. (2020). Central nervous system manifestations of COVID-19: A systematic review. Journal of the Neurological Sciences, 413, 116832.

Banerjee, D., & Viswanath, B. (2020). Neuropsychiatric manifestations of COVID-19 and possible pathogenic mechanisms: Insights from other coronaviruses. Asian Journal of Psychiatry, 54, 102350.

Beach, S. R., Praschan, N. C., Hogan, C., Dotson, S., Merideth, F., Kontos, N., Fricchione, G. L., & Smith, F. A. (2020). Delirium in COVID-19: A case series and exploration of potential mechanisms for central nervous system involvement. General Hospital Psychiatry, 65, 47–53.

Cezar-Junior, A. B., Faquini, I. V., Silva, J. L. J., de Carvalho Junior, E. V., Lemos, L. E. A. S., Freire Filho, J. B. M., de Lira Filho, H. T., Pontes, E. C. de A., Almeida, N. S., & Azevedo-Filho, H. R. C. (2020). Subarachnoid hemorrhage and COVID-19. Medicine, 99(51), e23862.

Cheng, Q., Yang, Y., & Gao, J. (2020). Infectivity of human coronavirus in the brain. EBioMedicine, 56, 102799.

Chia, K. X., Polakhare, S., & Bruno, S. D. (2020). Possible affective cognitive cerebellar syndrome in a young patient with COVID-19 CNS vasculopathy and stroke. BMJ Case Reports, 13(10), e237926.

Chirakkal, P., Al Hail, A. N., Zada, N., & Vijayakumar, D. S. (2020). COVID-19 and Tinnitus. Ear, Nose & Throat Journal, 100(2_suppl), 160S162S.

Divani, A. A., Andalib, S., Biller, J., Di Napoli, M., Moghimi, N., Rubinos, C. A., Nobleza, C. O., Sylaja, P. N., Toledano, M., Lattanzi, S., McCullough, L. D., Cruz-Flores, S., Torbey, M., & Azarpazhooh, M. R. (2020). Central Nervous System Manifestations Associated with COVID-19. Current Neurology and Neuroscience Reports, 20(12).

Gavriatopoulou, M., Korompoki, E., Fotiou, D., Ntanasis-Stathopoulos, I., Psaltopoulou, T., Kastritis, E., … Dimopoulos, M. A. (2020). Organ-specific manifestations of COVID-19 infection. Clinical and Experimental Medicine, 20(4), 493–506.

Gklinos, P. (2020). Neurological manifestations of COVID-19: a review of what we know so far. Journal of Neurology, 267(9), 2485–2489.

Hanafi, R., Roger, P.-A. ., Perin, B., Kuchcinski, G., Deleval, N., Dallery, F., Michel, D., Hacein-Bey, L., Pruvo, J.-P. ., Outteryck, O., & Constans, J.-M. . (2020). COVID-19 Neurologic Complication with CNS Vasculitis-Like Pattern. American Journal of Neuroradiology, 41(8), 1384–1387.

Hascup, E. R., & Hascup, K. N. (2020). Does SARS-CoV-2 infection cause chronic neurological complications? GeroScience, 1–5.

Heneka, M. T., Golenbock, D., Latz, E., Morgan, D., & Brown, R. (2020). Immediate and long-term consequences of COVID-19 infections for the development of neurological disease. Alzheimer’s Research & Therapy, 12(1).

Kasal, D. A., De Lorenzo, A., & Tibiriçá, E. (2020). COVID-19 and Microvascular Disease: Pathophysiology of SARS-CoV-2 Infection With Focus on the Renin-Angiotensin System. Heart, Lung and Circulation, 29(11), 1596–1602.

Koralnik, I. J., & Tyler, K. L. (2020). COVID ‐19: A Global Threat to the Nervous System. Annals of Neurology, 88(1), 1–11.

Kordzadeh-Kermani, E., Khalili, H., & Karimzadeh, I. (2020). Pathogenesis, clinical manifestations and complications of coronavirus disease 2019 (COVID-19). Future Microbiology, 15(13), 1287–1305.

Kumar, M., & Thakur, A. K. (2020). Neurological manifestations and comorbidity associated with COVID-19: an overview. Neurological Sciences.

Leonardi, M., Padovani, A., & McArthur, J. C. (2020). Neurological manifestations associated with COVID-19: a review and a call for action. Journal of Neurology, 267(6), 1573–1576.

Lim, K.-H., Yang, S., Kim, S.-H., & Joo, J.-Y. (2020). Elevation of ACE2 as a SARS-CoV-2 entry receptor gene expression in Alzheimer’s disease. Journal of Infection, 81(3), e33–e34.

Luigetti, M., Iorio, R., Bentivoglio, A. R., Tricoli, L., Riso, V., Marotta, J., Piano, C., Primiano, G., Zileri Del Verme, L., Lo Monaco, M. R., Calabresi, P., Abbate, V., Acampora, N., Addolorato, G., Agostini, F., Ainora, M. E., Akacha, K., Amato, E., Andreani, F., & Andriollo, G. (2020). Assessment of neurological manifestations in hospitalized patients with COVID‐19. European Journal of Neurology, 27(11), 2322–2328.

MacLean, M. A., Kamintsky, L., Leck, E. D., & Friedman, A. (2020). The potential role of microvascular pathology in the neurological manifestations of coronavirus infection. Fluids and Barriers of the CNS, 17(1).

Mao, L., Jin, H., Wang, M., Hu, Y., Chen, S., He, Q., … Hu, B. (2020). Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China. JAMA Neurology, 77(6), 683.

Mohammadi, S., Moosaie, F., & Aarabi, M. H. (2020). Understanding the Immunologic Characteristics of Neurologic Manifestations of SARS-CoV-2 and Potential Immunological Mechanisms. Molecular Neurobiology.

Nepal, G., Rehrig, J. H., Shrestha, G. S., Shing, Y. K., Yadav, J. K., Ojha, R., Pokhrel, G., Tu, Z. L., & Huang, D. Y. (2020). Neurological manifestations of COVID-19: a systematic review. Critical Care, 24(1).

Niazkar, H. R., Zibaee, B., Nasimi, A., & Bahri, N. (2020). The neurological manifestations of COVID-19: a review article. Neurological Sciences, 41(7), 1667–1671.

Orrù, G., Conversano, C., Malloggi, E., Francesconi, F., Ciacchini, R., & Gemignani, A. (2020). Neurological Complications of COVID-19 and Possible Neuroinvasion Pathways: A Systematic Review. International Journal of Environmental Research and Public Health, 17(18), 6688.

Payus, A. O., Liew Sat Lin, C., Mohd Noh, M., Jeffree, M. S., & Ali, R. A. (2020). SARS-CoV-2 infection of the nervous system: A review of the literature on neurological involvement in novel coronavirus disease (COVID-19). Bosnian Journal of Basic Medical Sciences.

Speth, M. M., Singer‐Cornelius, T., Oberle, M., Gengler, I., Brockmeier, S. J., & Sedaghat, A. R. (2020). Mood, Anxiety and Olfactory Dysfunction in COVID ‐19: Evidence of Central Nervous System Involvement? The Laryngoscope, 130(11), 2520–2525.

Steardo, L., Steardo, L., & Verkhratsky, A. (2020). Psychiatric face of COVID-19. Translational Psychiatry, 10(1).

Steardo, L., Steardo, L., Zorec, R., & Verkhratsky, A. (2020). Neuroinfection may contribute to pathophysiology and clinical manifestations of COVID‐19. Acta Physiologica, 229(3).

Yavarpour-Bali, H., & Ghasemi-Kasman, M. (2020). Update on neurological manifestations of COVID-19. Life Sciences, 257, 118063.

Zhou, Z., Kang, H., Li, S., & Zhao, X. (2020). Understanding the neurotropic characteristics of SARS-CoV-2: from neurological manifestations of COVID-19 to potential neurotropic mechanisms. Journal of Neurology, 267(8), 2179–2184.

Zoghi, A., Ramezani, M., Roozbeh, M., Darazam, I. A., & Sahraian, M. A. (2020). A case of possible atypical demyelinating event of the central nervous system following COVID-19. Multiple Sclerosis and Related Disorders, 44, 102324.

Zubair, A. S., McAlpine, L. S., Gardin, T., Farhadian, S., Kuruvilla, D. E., & Spudich, S. (2020). Neuropathogenesis and Neurologic Manifestations of the Coronaviruses in the Age of Coronavirus Disease 2019. JAMA Neurology, 77(8), 1018.

Manifestaciones clínicas relacionadas con el sistema nervioso derivadas del COVID-19: una revisión integradora

Autores/as

DOI:

Palabras clave:

Resumen

Citas

Descargas

Publicado

Cómo citar

Número

Sección

Licencia

JOURNAL METRICS

Idioma

Enviar un artículo